Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Objective: Moderately elevated levels of plasma total homocysteine are associated with an increased risk of developing Alzheimer's disease. We have tested whether baseline concentrations of homocysteine relate to the subsequent rate of cognitive decline in patients with established Alzheimer...
Հիմնական հեղինակներ: | Oulhaj, A, Refsum, H, Beaumont, H, Williams, J, King, E, Jacoby, R, Smith, A |
---|---|
Այլ հեղինակներ: | International College of Geriatric Psychoneuropharmacology |
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
John Wiley & Sons, Ltd.
2010
|
Խորագրեր: |
Նմանատիպ նյութեր
-
Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
: Oulhaj, A, և այլն
Հրապարակվել է: (2010) -
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
: Smith, A, և այլն
Հրապարակվել է: (2010) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
: de Jager, C, և այլն
Հրապարակվել է: (2012) -
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
: De Jager, C, և այլն
Հրապարակվել է: (2012) -
Cognitive deficits in severe mood disorder: similar or different from schizophrenia?
: Goodwin, G
Հրապարակվել է: (2003)